Skip to main content
Clinical Trials/ITMCTR2024000171
ITMCTR2024000171
Recruiting
Early Phase 1

Study on the clinical effect of pestle needle in the intervention of qi deficiency and blood stasis type ischemic Post-stroke Fatigue based on Fuzheng theory

Hospital of Chengdu University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Post-stroke Fatigue
Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. First\-time patients who meet the diagnostic criteria of Chinese and Western medicine for ischemic stroke;
  • 2\. TCM syndromes meet the diagnostic criteria of qi deficiency and blood stasis syndrome;
  • 3\. Ischemic stroke patients in the non\-acute stage;
  • 4\. Age \=18 years old;
  • 5\. The patient had no cognitive or mental disorders, stable vital signs, clear mind, and was able to complete the questionnaire or scale assessment;
  • 6\. Fatigue Severity Scale (FSS) score \=36 points;
  • 7\. Patients and their family members voluntarily participate in the subject and sign the subject informed consent.

Exclusion Criteria

  • 1\. Ischemic stroke patients in the acute stage;
  • 2\. Patients with transient ischemic attack;
  • 3\. Severe cardiovascular, liver, kidney diseases and moderate to severe infections;
  • 4\. Patients with known fatigue high incidence diseases such as malignant tumor, systemic lupus erythematosus, Parkinson's disease;
  • 5\. Patients with pre\-stroke fatigue;
  • 6\. A woman who is pregnant or breastfeeding;
  • 7\. The acupoint area has a large area of skin damage, metal contact allergy, etc., should not be pestle needle treatment;
  • 8\. Is participating other clinical investigators.

Outcomes

Primary Outcomes

Not specified

Similar Trials